| 3 min read
The therapy exploits the properties of a neutrophil-derived enzyme to selectively kill tumor cells while preserving healthy immune cells.
| 4 min read
FDA approvals, rejections, antibody-drug conjugate deals, and more led the news this week.
| 4 min read
Radiprodil is in development as the first therapy designed to directly address the underlying biology of GRIN-related neurodevelopmental disorder.News
| 3 min read
The sensor could be used to enhance personalized medicine approaches for a variety of conditions.
| 6 min read
With the first wave of FDA-approved siRNA drugs under their belt, companies are racing to expand into new tissues and indications.
| 3 min read
Researchers are using caraway seeds to create synthetic cannabidiol compounds for treating seizures.
| 2 min read
FDA greenlights Bayer’s first-in-class drug and non-hormonal option in the vasomotor-symptom space.
| 5 min read
Researchers and engineers are developing filtration systems that merge automation, analytics, and modular design to overcome long-standing purification challenges.
| 4 min read
Another biotech retreats from AAV, a promising antibiotic, a paused CRISPR trial, and more led the news this week.
| 3 min read
How a team at Pfizer turned a decade-old compound into the fastest small molecule drug for COVID-19.
| 4 min read
Researchers are turning bacterial transport systems from obstacles into opportunities for targeted therapy.
| 5 min read
Pulmonary fibrosis patients have long suffered through side effects from their drugs. That could change with the potential for new inhaled versions in clinical trials.
